Business Description
Tianjin Tianyao Pharmaceutical Co Ltd
NAICS : 325412
SIC : 2834
No. 109 Bawei Road, Hedong District, Tianjin, Tianjin, CHN, 300171
Compare
Compare
Traded in other countries / regions
600488.China
Description
Tianjin Tianyao Pharmaceutical Co Ltd is a China-based company engages in the development, manufacture, distribution, and export of pharmaceutical products. Its products include corticosteroids and cardiovascular medicine, dexamethasone, and cortisone acetate.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.19 | |||||
Equity-to-Asset | 0.47 | |||||
Debt-to-Equity | 0.48 | |||||
Debt-to-EBITDA | 9.27 | |||||
Interest Coverage | 4.11 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 2 | |||||
Beneish M-Score | -2.45 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 16 | |||||
3-Year EBITDA Growth Rate | 3.4 | |||||
3-Year EPS without NRI Growth Rate | -30.3 | |||||
3-Year FCF Growth Rate | -24.4 | |||||
3-Year Book Growth Rate | 0.6 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 38.7 | |||||
9-Day RSI | 39.08 | |||||
14-Day RSI | 42.41 | |||||
6-1 Month Momentum % | 4 | |||||
12-1 Month Momentum % | 6 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.94 | |||||
Quick Ratio | 0.49 | |||||
Cash Ratio | 0.13 | |||||
Days Inventory | 181.3 | |||||
Days Sales Outstanding | 50.16 | |||||
Days Payable | 106.71 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.33 | |||||
Dividend Payout Ratio | 0.23 | |||||
3-Year Dividend Growth Rate | -34.8 | |||||
Forward Dividend Yield % | 0.33 | |||||
5-Year Yield-on-Cost % | 0.24 | |||||
3-Year Average Share Buyback Ratio | -0.3 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 45.38 | |||||
Operating Margin % | 5.15 | |||||
Net Margin % | 1.21 | |||||
ROE % | 1.52 | |||||
ROA % | 0.72 | |||||
ROIC % | 2.62 | |||||
ROC (Joel Greenblatt) % | 3.85 | |||||
ROCE % | 3.51 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 98.84 | |||||
PE Ratio without NRI | 98.84 | |||||
Shiller PE Ratio | 41.11 | |||||
PEG Ratio | 11.91 | |||||
PS Ratio | 1.22 | |||||
PB Ratio | 1.55 | |||||
Price-to-Tangible-Book | 1.76 | |||||
Price-to-Operating-Cash-Flow | 15.4 | |||||
EV-to-EBIT | 37.75 | |||||
EV-to-EBITDA | 37.75 | |||||
EV-to-Revenue | 1.54 | |||||
EV-to-FCF | -108.6 | |||||
Price-to-Projected-FCF | 2.61 | |||||
Price-to-Median-PS-Value | 0.55 | |||||
Price-to-Graham-Number | 2.76 | |||||
Earnings Yield (Greenblatt) % | 2.65 | |||||
Forward Rate of Return (Yacktman) % | -7.23 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Executives
EMBED
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 3,791.753 | ||
EPS (TTM) (¥) | 0.043 | ||
Beta | 0.7 | ||
Volatility % | 33.65 | ||
14-Day RSI | 42.41 | ||
14-Day ATR (¥) | 0.101721 | ||
20-Day SMA (¥) | 4.364 | ||
12-1 Month Momentum % | 6 | ||
52-Week Range (¥) | 3.77 - 5.24 | ||
Shares Outstanding (Mil) | 1,100.05 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Tianjin Tianyao Pharmaceutical Co Ltd Filings
Document | Form | Filing Date | ||
---|---|---|---|---|
No Filing Data |